Delivery Order SPE2DB20D9226-SPE2DB24FQ55X

Award Date 10/24/23
Potential Completion Date 10/25/23
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $8,339.18 firm fixed-price order is for the supply of XTANDI 80 MG TABLET 60S, a prescription drug. This delivery order is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue firm fixed-price delivery...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $8,339.18 contract is for the delivery of the pharmaceutical product XTANDI 80 MG TABLET 60S. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 firm fixed-price contract is for the delivery of XTANDI 80 MG TABLET 60S, a specialty medication, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order, valued at $8,622.72, is for the supply of 120 capsules of the medication XTANDI 40 MG. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to...
This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the SPE2DB contract vehicle. The order, valued at $12,508.77, is for the supply of XTANDI 40 MG TABLET 120S to support the recurring pharmaceutical needs of the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $8,622.72 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to issue delivery orders for a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,622.72 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. The delivery order is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This contract award is a firm fixed-price delivery order valued at $8,339.18 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the supply of XTANDI 80 MG TABLET 60S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,847.95 contract is for the delivery of XTANDI 80 MG TABLET 60S and has a completion date of September 7, 2022. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,508.77, is for the delivery of XTANDI 40 MG TABLET 120S to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
  • SPE2DB20D9226
    Indefinite Delivery Contract
  • SPE2DB20D9226-SPE2DB24FQ55X
    Delivery Order

This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $8,339.18 order is for the supply of XTANDI 80 MG TABLET 60S, a prescription pharmaceutical product.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. This contract does not have a set-aside designation.

As a prime vendor to the DLA, DMS Pharmaceutical Group provides both routine and critical medications, biologics, and medical consumables to military health facilities globally, solidifying its position as a key supplier in the federal pharmaceutical supply chain.

Generated 1/9/25, 9:11 AM